201 related articles for article (PubMed ID: 15769928)
1. Cutaneous vasculitis developed in a patient with breast cancer undergoing aromatase inhibitor treatment.
Shoda H; Inokuma S; Yajima N; Tanaka Y; Setoguchi K
Ann Rheum Dis; 2005 Apr; 64(4):651-2. PubMed ID: 15769928
[No Abstract] [Full Text] [Related]
2. Cutaneous leukocytoclastic vasculitis associated with letrozole.
Digklia A; Tzika E; Voutsadakis IA
J Oncol Pharm Pract; 2014 Apr; 20(2):146-8. PubMed ID: 23676512
[TBL] [Abstract][Full Text] [Related]
3. Bortezomib-associated cutaneous vasculitis.
Garcia-Navarro X; Puig L; Fernández-Figueras MT; Dalmau J; Roe E; Alomar A
Br J Dermatol; 2007 Oct; 157(4):799-801. PubMed ID: 17635511
[No Abstract] [Full Text] [Related]
4. Rituximab-induced vasculitis.
Dereure O; Navarro R; Rossi JF; Guilhou JJ
Dermatology; 2001; 203(1):83-4. PubMed ID: 11549810
[No Abstract] [Full Text] [Related]
5. Leukocytoclastic vasculitis associated with use of aromatase inhibitors.
Woodford RG; Becker GJ; Jain A
Intern Med J; 2019 Sep; 49(9):1162-1167. PubMed ID: 31507048
[TBL] [Abstract][Full Text] [Related]
6. Quinine-induced cutaneous vasculitis.
Price EJ; Bevan JS; Rees A
Br J Clin Pract; 1992; 46(2):138-9. PubMed ID: 1457303
[TBL] [Abstract][Full Text] [Related]
7. Aromatase inhibitor-induced skin adverse reactions: exemestane-related cutaneous vasculitis.
Santoro S; Santini M; Pepe C; Tognetti E; Cortelazzi C; Ficarelli E; De Panfilis G
J Eur Acad Dermatol Venereol; 2011 May; 25(5):596-8. PubMed ID: 21492245
[TBL] [Abstract][Full Text] [Related]
8. Severe cutaneous thrombotic hypersensitivity vasculitis.
Giraldo F; Sanz A; Colmenero JD
Plast Reconstr Surg; 1997 Nov; 100(6):1623. PubMed ID: 9385997
[No Abstract] [Full Text] [Related]
9. Accelerated cutaneous nodulosis associated with aromatase inhibitor therapy in a patient with rheumatoid arthritis.
Chao J; Parker BA; Zvaifler NJ
J Rheumatol; 2009 May; 36(5):1087-8. PubMed ID: 19435976
[No Abstract] [Full Text] [Related]
10. Leukocytoclastic vasculitis induced by low-dose methotrexate: in vitro evidence for an immunologic mechanism.
Halevy S; Giryes H; Avinoach I; Livni E; Sukenik S
J Eur Acad Dermatol Venereol; 1998 Jan; 10(1):81-5. PubMed ID: 9552765
[TBL] [Abstract][Full Text] [Related]
11. Cutaneous vasculitis associated with rofecoxib.
Lillicrap MS; Merry P
Rheumatology (Oxford); 2003 Oct; 42(10):1267-8. PubMed ID: 14508048
[No Abstract] [Full Text] [Related]
12. Hexamethylene bisacetamide-induced cutaneous vasculitis.
Rowinsky EK; McGuire WP; Anhalt GJ; Ettinger DS; Donehower RC
Cancer Treat Rep; 1987 May; 71(5):471-4. PubMed ID: 3567971
[TBL] [Abstract][Full Text] [Related]
13. Vasculitis attributed to the nicotine patch (Nicotinell).
Van der Klauw MM; Van Hillo B; Van den Berg WH; Bolsius EP; Sutorius FF; Stricker BH
Br J Dermatol; 1996 Feb; 134(2):361-4. PubMed ID: 8746358
[TBL] [Abstract][Full Text] [Related]
14. [Allergic vasculitis following ingestion of celecoxib?].
Gscheidel D; Daspet MK; Le Coz CJ; Lipsker D
Hautarzt; 2002 Jul; 53(7):488-91. PubMed ID: 12219273
[TBL] [Abstract][Full Text] [Related]
15. Cutaneous vasculitis induced by cyclo-oxygenase-2 selective inhibitors.
Drago F; Brusati C; Desirello G; Cacciapuoti M; Rebora A
J Am Acad Dermatol; 2004 Dec; 51(6):1029-30. PubMed ID: 15583611
[No Abstract] [Full Text] [Related]
16. Some side effects of breast cancer treatment may be a good sign.
Harv Womens Health Watch; 2009 Jan; 16(5):6. PubMed ID: 19244663
[No Abstract] [Full Text] [Related]
17. New pharmacogenomic paradigm in breast cancer treatment.
Offit K; Robson ME
J Clin Oncol; 2010 Nov; 28(31):4665-6. PubMed ID: 20876427
[No Abstract] [Full Text] [Related]
18. Hypersensitivity vasculitis associated with streptokinase.
Thompson RF; Stratton MA; Heffron WA
Clin Pharm; 1985; 4(4):383, 386. PubMed ID: 2931234
[No Abstract] [Full Text] [Related]
19. Atypical Painful Purpuric Cutaneous Nodules With Ibrutinib.
Marcaillou M; Stéphanie D; Marion B; Julien S; Christophe B
Am J Dermatopathol; 2020 Dec; 42(12):1012-1014. PubMed ID: 32675466
[No Abstract] [Full Text] [Related]
20. [Ciprofloxacin-induced vasculitis with cutaneous and renal involvement].
Pons R; Escutia B
Nefrologia; 2001; 21(2):209-12. PubMed ID: 11464656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
